Javascript must be enabled to continue!
Assessment of STS-TR score for transcatheter tricuspid valve interventions: an international multicenter study
View through CrossRef
Abstract
Background
Transcatheter tricuspid valve intervention (TTVI) is increasingly utilized for symptomatic severe tricuspid regurgitation (TR), particularly in high-risk surgical patients. The Society of Thoracic Surgeons Tricuspid Regurgitation (STS-TR) score, that was developed for prediction of 30-day mortality after tricuspid valve surgery. The purpose of the current study is to evaluate the performance of the STS-TR score in patients who underwent TTVI.
Methods
A six-center international cohort of 457 patients who underwent TTVI for symptomatic severe or greater TR between 2019-2024 were assessed using the STS-TR score. TTVI included tricuspid edge-to-edge repair (T-TEER) (n=243), tricuspid valve replacement (TTVR) (n=131), and transcatheter tricuspid annuloplasty (TTA) (n=83). The STS-TR 30-day all-cause mortality score was calculated for each patient and compared to observed mortality. The performance of the STS-TR score was assessed using calibration plots, the Hosmer-Lemeshow (H-L) test, and C-statistic. Subgroup analyses were performed based on TTVI procedure type.
Results
Mean age was 78.6 ± 8.7 years, and 54.7% were female. The mean predicted 30-day all-cause STS-TR mortality was 8.16% ± 7.2%, while the observed mortality was 2.63% (p < 0.001). Subgroup analyses revealed similar calibration patterns, Figure 1. Calibration plots demonstrated overestimation across all procedure types. The C-statistic for the STS-TR score was 0.68 (95% CI: 0.54 - 0.82) (Figure 2), indicating suboptimal discrimination
Conclusions
The STS-TR score for isolated TR significantly overestimates TTVI 30-day mortality across all procedure types, including transcatheter repair (T-TEER and TTA) and replacement (TTVR), and demonstrates suboptimal discrimination. This may be related to lower risk of TTVI procedures compared to surgery or disparate cohorts. Prospective dedicated TTVI-specific risk prediction models for transcatheter repair and replacement procedures are needed.
Oxford University Press (OUP)
Title: Assessment of STS-TR score for transcatheter tricuspid valve interventions: an international multicenter study
Description:
Abstract
Background
Transcatheter tricuspid valve intervention (TTVI) is increasingly utilized for symptomatic severe tricuspid regurgitation (TR), particularly in high-risk surgical patients.
The Society of Thoracic Surgeons Tricuspid Regurgitation (STS-TR) score, that was developed for prediction of 30-day mortality after tricuspid valve surgery.
The purpose of the current study is to evaluate the performance of the STS-TR score in patients who underwent TTVI.
Methods
A six-center international cohort of 457 patients who underwent TTVI for symptomatic severe or greater TR between 2019-2024 were assessed using the STS-TR score.
TTVI included tricuspid edge-to-edge repair (T-TEER) (n=243), tricuspid valve replacement (TTVR) (n=131), and transcatheter tricuspid annuloplasty (TTA) (n=83).
The STS-TR 30-day all-cause mortality score was calculated for each patient and compared to observed mortality.
The performance of the STS-TR score was assessed using calibration plots, the Hosmer-Lemeshow (H-L) test, and C-statistic.
Subgroup analyses were performed based on TTVI procedure type.
Results
Mean age was 78.
6 ± 8.
7 years, and 54.
7% were female.
The mean predicted 30-day all-cause STS-TR mortality was 8.
16% ± 7.
2%, while the observed mortality was 2.
63% (p < 0.
001).
Subgroup analyses revealed similar calibration patterns, Figure 1.
Calibration plots demonstrated overestimation across all procedure types.
The C-statistic for the STS-TR score was 0.
68 (95% CI: 0.
54 - 0.
82) (Figure 2), indicating suboptimal discrimination
Conclusions
The STS-TR score for isolated TR significantly overestimates TTVI 30-day mortality across all procedure types, including transcatheter repair (T-TEER and TTA) and replacement (TTVR), and demonstrates suboptimal discrimination.
This may be related to lower risk of TTVI procedures compared to surgery or disparate cohorts.
Prospective dedicated TTVI-specific risk prediction models for transcatheter repair and replacement procedures are needed.
.
Related Results
Redo isolated tricuspid valve replacement in a patient with isolated persistent left superior vena cava: a case report
Redo isolated tricuspid valve replacement in a patient with isolated persistent left superior vena cava: a case report
Abstract
Background
Redo isolated tricuspid valve surgery has high in-hospital mortality and morbidity and is a challenging procedure. We report a s...
A Novel Transcatheter Edge-to-Edge Suturing Technique and Prototype for Repairing Tricuspid Valve Regurgitation
A Novel Transcatheter Edge-to-Edge Suturing Technique and Prototype for Repairing Tricuspid Valve Regurgitation
Abstract
Tricuspid valve regurgitation is a major clinical issue that continues to attract interest from interventional cardiologists and medical device designers du...
Comparison of Heart Valve Circumference Examined Before and After 10% Formalin Fixation
Comparison of Heart Valve Circumference Examined Before and After 10% Formalin Fixation
Objective: To compare the heart valve circumference before and after 10% formalin fixation. Materials and Methods: The study analyzed 63 Thai human cadaveric hearts. Each heart val...
Comparison of Valveplasty and Replacement for Surgical Treatment of Infective Tricuspid Valve Endocarditis
Comparison of Valveplasty and Replacement for Surgical Treatment of Infective Tricuspid Valve Endocarditis
Abstract
Background
In recent years, due to the increase in intravenous drug injection and intracardiac and vascular interventional treatments among drug users, infective ...
New generation software for evaluation of annular dynamics and reverse remodeling after transcatheter repair in patients with severe atrial functional tricuspid regurgitation
New generation software for evaluation of annular dynamics and reverse remodeling after transcatheter repair in patients with severe atrial functional tricuspid regurgitation
Abstract
Introduction
Functional tricuspid regurgitation (fTR) is the most common cause of TR. The routine imaging method of the...
The evolving role of multi-modality imaging in transcatheter tricuspid valve interventions
The evolving role of multi-modality imaging in transcatheter tricuspid valve interventions
Tricuspid valve pathophysiology is not well-understood. Emergence of novel transcatheter tricuspid therapies has fueled the requirements for improved imaging visualization techniqu...
The medtronic melody® transcatheter pulmonary valve implanted at 24‐mm diameter—it works
The medtronic melody® transcatheter pulmonary valve implanted at 24‐mm diameter—it works
ObjectivesWe report the Melody valve implanted and/or expanded to 24‐mm diameter.BackgroundThe Medtronic Melody valve has been implanted up to 22 mm in the pulmonary position for o...
An Acoustically Controlled Down-Hole Safety Valve (SCSSSV)
An Acoustically Controlled Down-Hole Safety Valve (SCSSSV)
American Institute of Mining, Metallurgical, and Petroleum Engineers, Inc.
Abstract
A surface-controlled subsurface safety valve...

